Jeffrey Kegarise, OD
Optometrist · Franklin, TNNPI 1841276904
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.7%), travel and lodging and other — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Biotissue Holdings Inc. at 24.9% of the total. Reporting peaked in 2024 at $4,927 and has fallen 92.7% since, to $358 in 2025. Among optometrist clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 203 payments — averaging $55.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$3K
- Alcon$2K
- Bausch & Lomb Americas Inc.$2K
- Johnson & Johnson Vision Care, Inc.$1K
- AbbVie$1K
- Carl Zeiss Meditec USA, Inc.$318
- plus $2K from 20 others
What the payments were for
- Consulting fees$8508%
- Travel & lodging$2,09119%
- Food & beverage$6,73060%
- Gifts$190%
- Other$1,59014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 24 | $2,806 |
| Alcon | 60 | $1,796 |
| Bausch & Lomb Americas Inc. | 13 | $1,713 |
| Johnson & Johnson Vision Care, Inc. | 25 | $1,388 |
| AbbVie(2 entities) | 12 | $1,130 |
| Carl Zeiss Meditec USA, Inc. | 1 | $318 |
| Sun Pharmaceutical Industries Inc. | 6 | $297 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $290 |
| Novartis | 17 | $242 |
| Maculogix, Inc. | 7 | $215 |
| Dompe US, Inc. | 3 | $179 |
| Coopervision Inc. | 6 | $164 |
| ABB Con-cise Optical Group LLC | 4 | $158 |
| Kala Pharmaceuticals, Inc. | 2 | $105 |
| Regeneron Healthcare Solutions, Inc. | 1 | $86 |
| Oyster Point Pharma, Inc. | 4 | $74 |
| Shire North American Group Inc | 1 | $66 |
| Eyevance Pharmaceuticals LLC | 4 | $64 |
| Optovue, Inc. | 1 | $32 |
| Mallinckrodt Hospital Products Inc. | 1 | $27 |
| Integra Lifesciences Corporation | 1 | $26 |
| Thea Pharma Inc. | 1 | $25 |
| AstraZeneca | 1 | $24 |
| Alcon Research LLC | 1 | $22 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Harrow Eye, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ScoutPro Osmolarity System$1,272
- VUITY$850
- Acuvue$691
- CIRRUS 5000$318
- Precision 1$273
- ARGOS$243
- INFUSE$220
- Oxervate$123
- DAILIES$123
- MIEBO$120
- XIIDRA$120
- CEQUA$117
How this compares
$11,282 in reported general payments places this provider in the 95th percentile of 1,122 optometrist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 12 | $16,706 |
| LumiganBimatoprost | 18 | $9,133 |
| Prednisolone Acetate | 35 | $1,577 |
| Latanoprost | 60 | $1,259 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 13 | $1,078 |
| Timolol Maleate | 24 | $279 |
| MoxifloxacinMoxifloxacin Hcl | 12 | $247 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan | $1,130 | $25,83930 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,122 optometrist providers in Tennessee.
Other optometrist in Franklin
- Tyler BooneFranklin$11K
- Ethan LyFranklin$7K
- Christopher LievensMemphis$566K
- Whitney HauserMemphis$330K
- Torrey CarlsonKingsport$192K
- Frances BynumMartin$162K
- Melvin FriedmanMemphis$108K
- Kurt SteeleNewport$90K
- Jennifer DrakeColumbia$84K
- Travis JohnsonMurfreesboro$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.